Kraig Biocraft LaboratoriesKBLB
13F holders, Q1 2026 (March 31)2holders +1
1new positions
0sold out
$0.11avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Kraig Biocraft Laboratories (KBLB) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Hurley Capital, LLC ($5K) and McIlrath & Eck, LLC ($1K).
- Company
- Kraig Biocraft Laboratories
- CUSIP
- 50075W104
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 12,952 shares bought, net +12,952 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Hurley Capital, LLC | 0.00% | No change | 50,000 | $5K |
| McIlrath & Eck, LLC | 0.00% | New | 12,952 | $1K |
"% of holder's portfolio" is KBLB's weight in each manager's 13F, not the share of Kraig Biocraft Laboratories the manager owns.